Ayesha Khan

Ayesha Khan

Auto-generated profile, based on publicly available information

Ayesha Khan

Nishtar Medical University and Hospital, Multan, Pakistan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2025 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
AKAllahdad Khan
Allahdad Khan
WUWaseef Ullah
Waseef Ullah
MIMoeen Ikram
Moeen Ikram
RQRameez Qasim
Rameez Qasim
UAUmama Alam
Umama Alam
RARaheel Ahmed
Raheel Ahmed
Background: Diabetes mellitus (DM) significantly increases the risk of cerebrovascular disease (CeVD), a major cause of mortality and long‐term disability. Despite improvements in healthcare, disparities in CeVD‐related mortality among diabetic populations in the United States persist. Methods: We conducted a retrospective analysis using the CDC WONDER database from 1999 to 2020 to assess mortality trends related to CeVD among adults aged ≥ 45 years with DM. Deaths were identified using ICD‐10 codes I60–I69 (CeVD) and E10–E14 (DM). Age‐adjusted mortality rates (AAMRs) were calculated, and trends were analysed using Joinpoint regression, stratified by age, race/ethnicity, geography, urbanisation, and place of death. Results: A total of 689,846 CeVD‐related deaths occurred in diabetic individuals. AAMR decreased from 36.9 in 1999 to 29.3 in 2020, with an average annual percentage change (AAPC) of −1.41%. However, a sharp rise was observed from 2018 to 2020 (APC 14.87%), indicating a concerning reversal in progress. The highest crude mortality rates were in the 75–84 age group, and the lowest in the 45–54 group. Black and Hispanic populations, rural residents, and those in the Southern United States had the highest mortality rates. The Northeast and Asian populations had the lowest, reflecting persistent disparities in access to care and preventive services. Conclusion: While CeVD mortality in diabetics declined over two decades, the recent reversal highlights emerging challenges, possibly due to healthcare disruptions and socioeconomic disparities. These findings underscore the need for targeted public health interventions to address inequities and improve outcomes in high‐risk populations.

14 September 2025 in ASIDE Internal Medicine
Verified
Journal Article
Open access
PDF file
MHMohamed Fawzi Hemida
Mohamed Fawzi Hemida
AKAyesha Khan
Ayesha Khan
AMAlyaa Ahmed Ahmed Ibrahim Mohamed
Alyaa Ahmed Ahmed Ibrahim Mohamed
AGAnika Goel
Anika Goel
KPKrish Patel
Krish Patel
ABAhmed Bahnasy
Ahmed Bahnasy
Introduction: Leukemia and ischemic heart disease (IHD) are major U.S. mortality causes. This study analyzes national mortality trends from 1999 to 2020 to assess the impact of public health efforts in leukemia-associated IHD mortality rates.Methods: This retrospective study analyzed death certificate data from the CDC-WONDER database spanning 1999 to 2020, focusing on leukemia (ICD-10: C91–C95) and ischemic heart disease (ICD-10: I20–I25) as multiple causes of mortality in the U.S. population. Crude mortality rates (CMR) and age-adjusted mortality rates (AAMR) per 100,000 population were calculated. JoinPoint analysis was performed to estimate annual percent change (APC) and average annual percent change (AAPC).Results: From 1999 to 2020, there were 53,603 deaths from combined leukemia and ischemic heart disease among U.S. adults aged 25+, with the AAMR declining from 1.39 to 1.09 per 100,000 (AAPC= -1.30%; 95% CI: -1.90 to -0.68; P= 0.000034). A significant decrease occurred from 1999 to 2018 (AAMR: 1.39 to 0.95; APC= -2.1894%; 95% CI: -2.3995 to -1.9788, P < 0.000001), followed by a period where the trend shifted upward which is statistically significant for the certain subgroups, except men and older adults. Men had higher AAMR than women (1.87 vs. 0.62). Regional AAMRs were highest in the Midwest (1.3). Non-Hispanic Whites had the highest AAMR (1.25). Adults 65+ had a CMR of 5.27 vs. 0.26 for ages 45–64.Conclusion: Significant health disparities exist, as mortality from combined leukemia and IHD is highest among men, older adults, rural populations, and non-Hispanic White individuals.

6 February 2025 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
RARizwan Ahmad
Rizwan Ahmad
SKSaad Khan
Saad Khan
AKAyesha Khan
Ayesha Khan
FAFaraz Arshad
Faraz Arshad
FNFatima Naveed
Fatima Naveed

25 February 2025 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
SKSaad Mbbs Khan
Saad Mbbs Khan
FAFaraz Arshad
Faraz Arshad
FNFatima Mbbs Naveed
Fatima Mbbs Naveed
RARizwan Mbbs Ahmad
Rizwan Mbbs Ahmad
AKAyesha Mbbs Khan
Ayesha Mbbs Khan

3 April 2025 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
AKAyesha Khan
Ayesha Khan
SKSaad Khan
Saad Khan
RARizwan Ahmad
Rizwan Ahmad
FNFatima Naveed
Fatima Naveed
FAFaraz Arshad
Faraz Arshad

7 December 2024 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Open access
RARizwan Ahmad
Rizwan Ahmad
SKSaad Khan
Saad Khan
AKAyesha Khan
Ayesha Khan
FAFaraz Arshad
Faraz Arshad
FNFatima Naveed
Fatima Naveed